维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Pridgen"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Nanoparticle technologies for cancer therapy显示文摘	Alexisr F Pridgen EM Langer R	2010	Handb Exp Pharmacol2010，，197：	1
2	Factors affecting the clearance and biodistribution of polymeric nanoparti- cles显示文摘	Alexis F Pridgen E Molnar L K	2008	Mol Pharm2008，5，4：	1
3	DNA Self‐Assembly of Targeted Near‐Infrared‐Responsive Gold Nanoparticles for Cancer Thermo‐Chemotherapy显示文摘	Zeyu Xiao Changwei Ji Jinjun Shi Eric M. Pridgen Jillian Frieder Jun Wu Omid C. Farokhzad	2012	Angew Chem Int Ed2012，，47：	1
4	Factors affecting the clearance and biodistribution of polymeric nanoparticles 显示文摘	ALEXIS F PRIDGEN E MOLNAR LK	2008	Mol Pharm2008，5，4：	1
5	Biodegradable polymeric nanoparticle delivery systems for cancer therapy显示文摘	Pridgen E M Langer R Farokhzad O C	2007	Nanomed2007，2，：	1
6	factors affecting the clearance and biodistribution of polymeric nanoparticles 显示文摘	Alexis F Pridgen E Molner L K	2008	molecular Pharma- ceutics2008，5，：	1
7	Flexor tendon tissue engineering:acellularization of human flexor tendons with preservation of biomechanical properties and biocompati- bility显示文摘	Pridgen BC Woon CY Kim K	2011	Tissue Eng Part C Methods2011，17，8：	1
8	Biodegradable, polymeric nanoparticle delivery systems for cancer therapy 显示文摘	PRIDGEN EM LANGER R FAROKHZAD OC	2007	Nanomedicine (Lond)2007，2，5：	1
9	Factors affecting the clearance and biodistribution of polymeric nanoparticles显示文摘	Alexis F Pridgen E Molnar LK		0，，04：	1
10	Factors affecting the clearance and biodistribution of polymeric nanoparticles 显示文摘	Alexis F Pridgen E Molnar LK	2008	Mol Pharm2008，5，4：	1
11	查看详情显示文摘	Alexis F Pridgen E Molnar L K Farokhzad O C		0，，04：	1
12	Factors affecting the clearance and biodistribution of polymeric nanopar- ticles 显示文摘	ALEXIS F PRIDGEN E MOLNAR L K	2008	Mol Pharmaceut2008，5，4：	1
13	Factors affecting the clear- ance and biodistribution of polymeric nanoparticles 显示文摘	Alexis F Pridgen E Molnar L K	2008	Mol Pharm2008，5，4：	1
14	Factors affecting the clear-ance and biodistribution of polymeric nanoparticles 显示文摘	Alexis F Pridgen E Molnar LK	2008	Mol Pharm2008，5，4：	1
15	Polymeric nanop- article technologies for oral drug delivery 显示文摘	PRIDGEN E M ALEXIS F FAROKHZAD O C	2014	Clin Gastroentero! Hepatol2014，12，10：	1
16	Hyperglycemic Ins2Akita Ldlr-mice show severely elevated lipid levels and increased atherosclerosis:a model of type 1 diabetic macrovascular disease显示文摘	Zhou C Pridgen B King N	2011	J Lipid Res2011，52，8：	1
17	Audit committees and internal control quality:evidence from nonprofit hospitals subieet to the single audit act显示文摘	Pridgen A Wang KJ	2012	Int J Audit2012，16，2：	1
18	Single-pot reductive conversion of amino acids to their respective 2-oxazolidinones employing trichloromethyl chloroformate as the acylating agent: A multigram synthesis 显示文摘	Pridgen L N Jr J P	1989	J Org Chem1989，54，：	1
19	Genetic predisposition toformation of calcium oxalate renal calculi 显示文摘	Resnick M Pridgen DB Goodman HO	1968	N Engl J Med1968，278，24：	1
20	A new regiosele-ctive synthesis of1,2,5-trisubstitued 1 H-imidazoles and its applic-ation to the developmentof eprosartan显示文摘	Shilocrat SC Mokhallalati MK Pridgen LN	1997	J Org Cjem1997，62，24：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示